Suppr超能文献

[头部穴位透刺对常年性变应性鼻炎的影响]

[Effect of penetrating needling at head acupoints on perennial allergic rhinitis].

作者信息

Wang Hao, Li Wei, Ju Xiao-Fang, Yu Xiao-Gang

机构信息

Beijing University of CM, Beijing 100029, China.

出版信息

Zhongguo Zhen Jiu. 2013 Sep;33(9):789-92.

Abstract

OBJECTIVE

To evaluate the effects and safety of penetrating needling on head acupoints for perennial allergic rhinitis (PAR).

METHODS

Eighty-one cases of PAR were randomly divided into an acupuncture group (41 cases) and a medication group (40 cases). Penetrating needling at head acupoints was adopted from Baihui (GV 20) to Qianding (GV 21) and from Shangxing (GV 23) to Shenting (GV 24) in the acupuncture group. A to tal 4-week treatment was given to the patients with 3 treatments a week. Loratadine tablet and azelastine hydrochloride nasal spray were given to the medication group continuously for 12 days. A follow-up was carried out 3 months after the treatment. The efficacy, symptom score and physical sign score, and side accidents were observed in both groups.

RESULTS

The total effective rate was 95.1% (39/41) in the acupuncture group, which was better than 82.5% (33/40) in the medication group (P < 0.05). The total scores of clinical symptoms and each partial scores after the treatment, and total scores of clinical symptoms in follow-up were obviously decreased in both groups (all P < 0.01), the nasal obstruction score and the total scores of clinical symptoms in the acupuncture group were better than those in the medication group (P < 0.01, P < 0.05). Obvious side-effect had not been found during the treatment.

CONCLUSION

Penetrating needling at head acupoints is a safe therapy for patients with PAR, and favorable effects can be found in both short term and long term.

摘要

目的

评价头部穴位透刺治疗常年性变应性鼻炎(PAR)的疗效及安全性。

方法

将81例PAR患者随机分为针刺组(41例)和药物组(40例)。针刺组采用从百会(GV 20)透至前顶(GV 21)、从神庭(GV 24)透至上星(GV 23)的头部穴位透刺法。患者每周治疗3次,共治疗4周。药物组给予氯雷他定片及盐酸氮卓斯汀鼻喷雾剂,连续用药12天。治疗后3个月进行随访。观察两组的疗效、症状评分与体征评分及不良反应。

结果

针刺组总有效率为95.1%(39/41),优于药物组的82.5%(33/40)(P < 0.05)。两组治疗后临床症状总分及各分项评分、随访时临床症状总分均明显降低(均P < 0.01),针刺组鼻塞评分及临床症状总分优于药物组(P < 0.01,P < 0.05)。治疗期间未发现明显不良反应。

结论

头部穴位透刺对PAR患者是一种安全的治疗方法,短期和长期均有良好疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验